Agilent Technologies, Inc. (NYSE:A) shares reached a new 52-week high during trading on Thursday after the company announced a dividend. The company traded as high as $68.81 and last traded at $67.31, with a volume of 2042200 shares. The stock had previously closed at $67.46.

The newly announced dividend which will be paid on Wednesday, January 24th. Shareholders of record on Tuesday, January 2nd will be given a dividend of $0.149 per share. This is a boost from Agilent Technologies’s previous quarterly dividend of $0.13. This represents a $0.60 annualized dividend and a yield of 0.89%. Agilent Technologies’s payout ratio is presently 27.32%.

Several research firms have issued reports on A. Zacks Investment Research cut Agilent Technologies from a “buy” rating to a “hold” rating in a research report on Thursday. Morgan Stanley reiterated an “overweight” rating on shares of Agilent Technologies in a research report on Tuesday. Robert W. Baird reiterated a “buy” rating and set a $70.00 target price on shares of Agilent Technologies in a research report on Friday, October 20th. Cowen and Company reiterated a “hold” rating and set a $65.00 target price on shares of Agilent Technologies in a research report on Thursday, September 28th. Finally, Goldman Sachs Group, Inc. (The) reiterated a “neutral” rating and set a $68.00 target price on shares of Agilent Technologies in a research report on Tuesday, September 26th. Five analysts have rated the stock with a hold rating and ten have issued a buy rating to the company’s stock. Agilent Technologies presently has a consensus rating of “Buy” and an average target price of $66.70.

The company has a current ratio of 3.22, a quick ratio of 2.76 and a debt-to-equity ratio of 0.39. The company has a market capitalization of $21,710.52, a P/E ratio of 29.46, a PEG ratio of 2.64 and a beta of 1.27.

Agilent Technologies (NYSE:A) last posted its earnings results on Tuesday, August 15th. The medical research company reported $0.59 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.52 by $0.07. Agilent Technologies had a return on equity of 16.95% and a net margin of 14.36%. The firm had revenue of $1.11 billion for the quarter, compared to analyst estimates of $1.09 billion. During the same quarter in the prior year, the company earned $0.49 EPS. Agilent Technologies’s revenue was up 6.7% on a year-over-year basis. equities analysts forecast that Agilent Technologies, Inc. will post 2.32 EPS for the current year.

In other Agilent Technologies news, CFO Didier Hirsch sold 15,555 shares of the stock in a transaction on Friday, September 15th. The stock was sold at an average price of $66.00, for a total transaction of $1,026,630.00. Following the transaction, the chief financial officer now owns 178,557 shares of the company’s stock, valued at approximately $11,784,762. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Also, CEO Michael R. Mcmullen sold 16,492 shares of the stock in a transaction on Thursday, September 14th. The stock was sold at an average price of $65.33, for a total value of $1,077,422.36. Following the transaction, the chief executive officer now directly owns 211,872 shares in the company, valued at approximately $13,841,597.76. The disclosure for this sale can be found here. In the last ninety days, insiders sold 152,713 shares of company stock worth $9,682,305.

Several institutional investors have recently modified their holdings of A. Advisor Group Inc. raised its position in shares of Agilent Technologies by 0.3% in the 2nd quarter. Advisor Group Inc. now owns 3,959 shares of the medical research company’s stock worth $235,000 after buying an additional 10 shares during the period. Bronfman E.L. Rothschild L.P. raised its position in shares of Agilent Technologies by 0.8% in the 2nd quarter. Bronfman E.L. Rothschild L.P. now owns 4,658 shares of the medical research company’s stock worth $276,000 after buying an additional 35 shares during the period. Veritable L.P. raised its position in shares of Agilent Technologies by 0.4% in the 2nd quarter. Veritable L.P. now owns 10,896 shares of the medical research company’s stock worth $646,000 after buying an additional 40 shares during the period. Balentine LLC raised its position in shares of Agilent Technologies by 2.9% in the 2nd quarter. Balentine LLC now owns 1,794 shares of the medical research company’s stock worth $106,000 after buying an additional 50 shares during the period. Finally, Kingfisher Capital LLC raised its position in shares of Agilent Technologies by 0.3% in the 2nd quarter. Kingfisher Capital LLC now owns 22,643 shares of the medical research company’s stock worth $1,343,000 after buying an additional 58 shares during the period.

COPYRIGHT VIOLATION NOTICE: This story was first posted by The Cerbat Gem and is owned by of The Cerbat Gem. If you are viewing this story on another site, it was stolen and republished in violation of U.S. and international trademark and copyright legislation. The original version of this story can be read at https://www.thecerbatgem.com/2017/11/16/agilent-technologies-inc-a-hits-new-52-week-high-following-dividend-announcement.html.

About Agilent Technologies

Agilent Technologies, Inc provides application focused solutions that include instruments, software, services and consumables for the entire laboratory workflow. The Company serves the life sciences, diagnostics and applied chemical markets. It has three business segments: life sciences and applied markets business, diagnostics and genomics business, and Agilent CrossLab business.

Receive News & Stock Ratings for Agilent Technologies Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies Inc. and related stocks with our FREE daily email newsletter.